NeuroSense Investor Relations - Events

Skip to content

Home
Research & Development
- PrimeC
- Paradigm
- Pipeline
About
- About NeuroSense
- Team
Publications & News
- Blog
- From the Media
Investors
Contact Us
- Contact Us
- Careers

Menu

Home
Research & Development
- PrimeC
- Paradigm
- Pipeline
About
- About NeuroSense
- Team
Publications & News
- Blog
- From the Media
Investors
Contact Us
- Contact Us
- Careers

Home
Research & Development
- PrimeC
- Paradigm
- Pipeline
About
- About NeuroSense
- Team
Publications & News
- Blog
- From the Media
Investors
Contact Us
- Contact Us
- Careers

Menu

Home
Research & Development
- PrimeC
- Paradigm
- Pipeline
About
- About NeuroSense
- Team
Publications & News
- Blog
- From the Media
Investors
Contact Us
- Contact Us
- Careers

Home
Board of Directors
News
Events (current)
SEC Filings
Stock
- Interactive Chart
- Investment Calculator
Governance
Presentations
Investor Alerts

Investor RelationsClick here to open mobile navigation

Home
Board of Directors
News
Events (current)
SEC Filings
Stock
- Interactive Chart (current)
- Investment Calculator (current)
Governance
Presentations
Investor Alerts

09-799-6183
info@neurosense-tx.com
One Broadway, Broadway, Cambridge, MA, USA
Ha-Menofim 11, Herzliya, Israel

Home

Investors
Contact Us
Careers

Menu

Investors
Contact Us
Careers

Research

PrimeC
Paradigm
Pipeline

Menu

PrimeC
Paradigm
Pipeline

About

About NeuroSense
Our Team

Menu

About NeuroSense
Our Team

Publications

Blog
From the Media

Menu

Blog
From the Media

© NeuroSense Therapeutics 2024 All Rights Reserved | Privacy Policy | Terms | Accessibility

Skip to content

Accessibility Tools

Increase Text
Decrease Text
Grayscale
High Contrast
Negative Contrast
Light Background
Links Underline
Readable Font
Reset